1. Introduction
1.1 Business Market Insights Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Market Insights
2.2 Market Attractiveness
3. Research Methodology
3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Hypothesis formulation:
- 3.2.2 Macro-economic factor analysis:
- 3.2.3 Developing base number:
- 3.2.4 Data Triangulation:
- 3.2.5 Country level data:
4. North America Radiation Oncology Market Landscape
4.1 Market Overview
4.2 Porter's Five Forces Analysis
- 4.2.1 Bargaining Power of Suppliers
- 4.2.2 Bargaining Power of Buyers
- 4.2.3 Threat of New Entrants
- 4.2.4 Competitive Rivalry
- 4.2.5 Threat of Substitutes
4.3 Ecosystem Analysis
- 4.3.1 Raw Material Suppliers
- 4.3.2 Manufacturers
- 4.3.3 Distributors/Suppliers
- 4.3.4 End Users
5. North America Radiation Oncology Market – Key Market Dynamics
5.1 Growth Drivers
- 5.1.1 Increasing Prevalence of Cancer
5.2 Market Opportunities
- 5.2.1 Strategic Initiatives
5.3 Future Trends
- 5.3.1 Technological advancements
5.4 Impact of Drivers and Restraints
6. North America Radiation Oncology Market Regional Analysis
6.1 North America Radiation Oncology Market Overview
6.2 North America Radiation Oncology Market Revenue 2021-2031 (US$ Million)
6.3 North America Radiation Oncology Market Forecast Analysis
7. North America Radiation Oncology Market Analysis – by Types
7.1 External Beam Radiation Therapy
- 7.1.1 Overview
- 7.1.2 External Beam Radiation Therapy: North America Radiation Oncology Market – Revenue and Forecast to 2031 (US$ Million)
7.2 Internal Beam Radiation Therapy
- 7.2.1 Overview
- 7.2.2 Internal Beam Radiation Therapy: North America Radiation Oncology Market – Revenue and Forecast to 2031 (US$ Million)
8. North America Radiation Oncology Market Analysis – by Application
8.1 Breast Cancer
- 8.1.1 Overview
- 8.1.2 Breast Cancer: North America Radiation Oncology Market – Revenue and Forecast to 2031 (US$ Million)
8.2 Prostate Cancer
- 8.2.1 Overview
- 8.2.2 Prostate Cancer: North America Radiation Oncology Market – Revenue and Forecast to 2031 (US$ Million)
8.3 Lung Cancer
- 8.3.1 Overview
- 8.3.2 Lung Cancer: North America Radiation Oncology Market – Revenue and Forecast to 2031 (US$ Million)
8.4 Head & Neck Cancer
- 8.4.1 Overview
- 8.4.2 Head & Neck Cancer: North America Radiation Oncology Market – Revenue and Forecast to 2031 (US$ Million)
8.5 Cervical Cancer
- 8.5.1 Overview
- 8.5.2 Cervical Cancer: North America Radiation Oncology Market – Revenue and Forecast to 2031 (US$ Million)
9. North America Radiation Oncology Market – North America Analysis
9.1 North America
- 9.1.1 North America Radiation Oncology Market Breakdown, by Key
Country, 2024 and 2031 (%)
- 9.1.1.1 North America Radiation Oncology Market – Revenue and
Forecast Analysis – by Country
- 9.1.1.1 US:
North America Radiation Oncology Market – Revenue and Forecast to 2031 (US$ Million)
- 9.1.1.1.1 US: North America Radiation Oncology Market Breakdown, by Types
- 9.1.1.1.2 US: North America Radiation Oncology Market Breakdown, by Application
- 9.1.1.2 Canada:
North America Radiation Oncology Market – Revenue and Forecast to 2031 (US$ Million)
- 9.1.1.2.1 Canada: North America Radiation Oncology Market Breakdown, by Types
- 9.1.1.2.2 Canada: North America Radiation Oncology Market Breakdown, by Application
- 9.1.1.3 Mexico :
North America Radiation Oncology Market – Revenue and Forecast to 2031 (US$ Million)
- 9.1.1.3.1 Mexico : North America Radiation Oncology Market Breakdown, by Types
- 9.1.1.3.2 Mexico : North America Radiation Oncology Market Breakdown, by Application
10. Competitive Landscape
10.1 Heat Map Analysis
10.2 Company Positioning and Concentration
11. North America Radiation Oncology Market Industry Landscape
11.1 Overview
11.2 Mergers and Acquisitions
11.3 Agreements, Collaborations, and Joint Ventures
11.4 New Product Launches
11.5 Expansions and Other Strategic Developments
12. Company Profiles
12.1 Varian Medical Systems Inc.
- 12.1.1 Key Facts
- 12.1.2 Business Description
- 12.1.3 Products and Services
- 12.1.4 Financial Overview
- 12.1.5 SWOT Analysis
- 12.1.6 Key Developments
12.2 Elekta AB.
- 12.2.1 Key Facts
- 12.2.2 Business Description
- 12.2.3 Products and Services
- 12.2.4 Financial Overview
- 12.2.5 SWOT Analysis
- 12.2.6 Key Developments
12.3 Accuray Incorporated.
- 12.3.1 Key Facts
- 12.3.2 Business Description
- 12.3.3 Products and Services
- 12.3.4 Financial Overview
- 12.3.5 SWOT Analysis
- 12.3.6 Key Developments
12.4 IBA Worldwide (Ion Beam Applications SA).
- 12.4.1 Key Facts
- 12.4.2 Business Description
- 12.4.3 Products and Services
- 12.4.4 Financial Overview
- 12.4.5 SWOT Analysis
- 12.4.6 Key Developments
12.5 Becton Dickinson and Co.
- 12.5.1 Key Facts
- 12.5.2 Business Description
- 12.5.3 Products and Services
- 12.5.4 Financial Overview
- 12.5.5 SWOT Analysis
- 12.5.6 Key Developments
12.6 Perspective Therapeutics Inc.
- 12.6.1 Key Facts
- 12.6.2 Business Description
- 12.6.3 Products and Services
- 12.6.4 Financial Overview
- 12.6.5 SWOT Analysis
- 12.6.6 Key Developments
12.7 NTP RADIOISOTOPES.
- 12.7.1 Key Facts
- 12.7.2 Business Description
- 12.7.3 Products and Services
- 12.7.4 Financial Overview
- 12.7.5 SWOT Analysis
- 12.7.6 Key Developments
12.8 Mallinckrodt Plc.
- 12.8.1 Key Facts
- 12.8.2 Business Description
- 12.8.3 Products and Services
- 12.8.4 Financial Overview
- 12.8.5 SWOT Analysis
- 12.8.6 Key Developments
12.9 Provision Healthcare.
- 12.9.1 Key Facts
- 12.9.2 Business Description
- 12.9.3 Products and Services
- 12.9.4 Financial Overview
- 12.9.5 SWOT Analysis
- 12.9.6 Key Developments
12.10 Curium.
- 12.10.1 Key Facts
- 12.10.2 Business Description
- 12.10.3 Products and Services
- 12.10.4 Financial Overview
- 12.10.5 SWOT Analysis
- 12.10.6 Key Developments
13. Appendix
13.1 About Business Market Insights
Get Free Sample For North America Radiation Oncology Market
